These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 18774334

  • 1. All clinical trials are not created equal: The dilemma of HEAAL.
    Hauptman PJ.
    Eur J Heart Fail; 2008 Sep; 10(9):817-8. PubMed ID: 18774334
    [No Abstract] [Full Text] [Related]

  • 2. Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor.
    Konstam MA, Poole-Wilson PA, Dickstein K, Drexler H, Justice SJ, Komajda M, Malbecq W, Martinez FA, Neaton JD, Riegger GA, Guptha S.
    Eur J Heart Fail; 2008 Sep; 10(9):899-906. PubMed ID: 18768350
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 4. [Combination of ACEI and ARB therapy for heart failure].
    Nishikimi T, Matsuoka H.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():140-4. PubMed ID: 17569311
    [No Abstract] [Full Text] [Related]

  • 5. A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment.
    Hu DY, Huang J, Cai NS, Zhu WL, Li YS, Massaad R, Hanson ME, Dickstein K.
    Chin Med J (Engl); 2012 Nov 28; 125(21):3868-74. PubMed ID: 23106890
    [Abstract] [Full Text] [Related]

  • 6. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA, Das S, O'Keefe JH.
    Heart Fail Clin; 2006 Jan 28; 2(1):81-8. PubMed ID: 17386879
    [No Abstract] [Full Text] [Related]

  • 7. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA, Movahed A.
    Rev Cardiovasc Med; 2005 Jan 28; 6(4):206-13. PubMed ID: 16379016
    [Abstract] [Full Text] [Related]

  • 8. Underuse of evidence-based therapies.
    Hlatky MA.
    Circulation; 2004 Aug 10; 110(6):644-5. PubMed ID: 15302805
    [No Abstract] [Full Text] [Related]

  • 9. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 10. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors].
    Berger D.
    Internist (Berl); 2000 Jan 16; 41(1):A37. PubMed ID: 10712087
    [No Abstract] [Full Text] [Related]

  • 11. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M, Solomon SD.
    Curr Opin Cardiol; 2006 Jul 16; 21(4):268-72. PubMed ID: 16755193
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S, Millozzi F, Scarlata S.
    Clin Ter; 2001 Jul 16; 152(2):77-8. PubMed ID: 11441526
    [No Abstract] [Full Text] [Related]

  • 13. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
    McCall KL, Craddock D, Edwards K.
    Pharmacotherapy; 2006 Sep 16; 26(9):1297-306. PubMed ID: 16945052
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II type 1 receptor blockers and congestive heart failure.
    Auer JW, Berent R, Eber B.
    Circulation; 2001 Oct 09; 104(15):E82. PubMed ID: 11591633
    [No Abstract] [Full Text] [Related]

  • 15. [Diastolic heart failure -- a disease of the elderly].
    Witthaut R.
    Dtsch Med Wochenschr; 2005 Mar 24; 130(12):704-9. PubMed ID: 15776355
    [No Abstract] [Full Text] [Related]

  • 16. [The HEAAL study].
    Volpe M, Taddei S.
    G Ital Cardiol (Rome); 2010 Sep 24; 11(9):625-9. PubMed ID: 21348177
    [No Abstract] [Full Text] [Related]

  • 17. Effect of combination angiotensin-converting enzyme and angiotensin receptor blocker therapy on heart failure mortality and morbidity.
    Kapoor JR.
    Am J Cardiol; 2008 Mar 01; 101(5):744-5. PubMed ID: 18308033
    [No Abstract] [Full Text] [Related]

  • 18. Are angiotensin II receptor antagonists indicated in chronic heart failure?
    Komajda M.
    Heart Fail Monit; 2002 Mar 01; 2(3):85-7. PubMed ID: 12634889
    [Abstract] [Full Text] [Related]

  • 19. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P.
    J Hypertens; 2008 Jul 01; 26(7):1282-9. PubMed ID: 18550998
    [Abstract] [Full Text] [Related]

  • 20. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G.
    Nephrol Ther; 2010 Jan 01; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.